Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$898M |
| 2 |
lululemon athletica
LULU
|
$635M |
| 3 |
Wells Fargo
WFC
|
$507M |
| 4 |
Accenture
ACN
|
$479M |
| 5 |
Phillips 66
PSX
|
$448M |
Top Sells
| 1 |
JPMorgan Chase
JPM
|
$858M |
| 2 |
PepsiCo
PEP
|
$844M |
| 3 |
YHOO
Yahoo Inc
YHOO
|
$721M |
| 4 |
APC
Anadarko Petroleum
APC
|
$688M |
| 5 |
Cisco
CSCO
|
$670M |
Sector Composition
| 1 | Healthcare | 21.18% |
| 2 | Financials | 14.5% |
| 3 | Technology | 12.07% |
| 4 | Industrials | 11.14% |
| 5 | Energy | 10.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Merck
MRK
$210B
| $6.88B | 2.15% | 144,476,462 +536,033 | +0.4% | +$25.5M |
|
|
2
Wells Fargo
WFC
$263B
| $5.53B | 1.73% | 133,921,197 +12,260,837 | +10% | +$507M |
|
3
Chevron
CVX
$324B
| $4.79B | 1.5% | 39,441,785 +2,860,285 | +8% | +$348M |
|
4
Exxon Mobil
XOM
$487B
| $4.67B | 1.46% | 54,306,094 +212,158 | +0.4% | +$18.3M |
|
5
Microsoft
MSFT
$3.77T
| $4.3B | 1.35% | 128,989,190 -12,465,421 | -9% | -$415M |
|
|
6
JPMorgan Chase
JPM
$829B
| $4.11B | 1.29% | 79,445,038 -16,599,034 | -17% | -$858M |
|
7
Johnson & Johnson
JNJ
$427B
| $4.01B | 1.26% | 46,248,667 -2,824,938 | -6% | -$245M |
|
|
8
Bristol-Myers Squibb
BMY
$96B
| $3.64B | 1.14% | 78,723,526 +19,398,830 | +33% | +$898M |
|
9
Lowe's Companies
LOW
$145B
| $3.63B | 1.14% | 76,181,168 -5,843,468 | -7% | -$278M |
|
10
UnitedHealth
UNH
$281B
| $3.54B | 1.11% | 49,482,512 -937,719 | -2% | -$67.2M |
|
|
11
Cisco
CSCO
$274B
| $3.12B | 0.98% | 133,226,899 -28,614,588 | -18% | -$670M |
|
12
PNC Financial Services
PNC
$81.7B
| $3.11B | 0.97% | 42,905,607 +187,760 | +0.4% | +$13.6M |
|
13
Pfizer
PFE
$141B
| $3.02B | 0.95% | 105,294,706 -5,152,852 | -5% | -$148M |
|
14
CVS Health
CVS
$92.8B
| $2.73B | 0.86% | 48,177,933 +562,083 | +1% | +$31.9M |
|
15
Eli Lilly
LLY
$657B
| $2.68B | 0.84% | 53,305,452 +2,887,881 | +6% | +$145M |
|
16
Medtronic
MDT
$119B
| $2.68B | 0.84% | 50,267,134 -833,753 | -2% | -$44.4M |
|
17
Blackrock
BLK
$175B
| $2.61B | 0.82% | 9,640,235 +151,166 | +2% | +$40.9M |
|
18
Verizon
VZ
$186B
| $2.55B | 0.8% | 54,727,280 +9,504,781 | +21% | +$443M |
|
19
Citigroup
C
$178B
| $2.39B | 0.75% | 49,202,581 +2,033,717 | +4% | +$98.7M |
|
20
Gilead Sciences
GILD
$140B
| $2.37B | 0.74% | 37,637,927 -807,222 | -2% | -$50.7M |
|
21
Chubb
CB
$110B
| $2.35B | 0.74% | 25,110,942 +1,380,213 | +6% | +$129M |
|
|
APC
22
DELISTED
Anadarko Petroleum
APC
| $2.3B | 0.72% | 24,689,496 -7,401,922 | -23% | -$688M |
|
23
Amgen
AMGN
$155B
| $2.29B | 0.72% | 20,433,097 +357,846 | +2% | +$40.1M |
|
24
Teva Pharmaceuticals
TEVA
$21.1B
| $2.23B | 0.7% | 59,004,813 -2,235,005 | -4% | -$84.4M |
|
25
Intel
INTC
$107B
| $2.23B | 0.7% | 97,100,434 -19,299,141 | -17% | -$442M |
|